Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Truist Financial Reaffirms Their Hold Rating on Humana (HUM)

Tipranks - Tipranks - Tue Feb 17, 8:34PM CST

Truist Financial analyst David S Macdonald maintained a Hold rating on Humana yesterday and set a price target of $200.00.

President's Day Sale - 70% Off

S Macdonald covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Tenet Healthcare, and PACS Group Inc. According to TipRanks, S Macdonald has an average return of 10.6% and a 58.20% success rate on recommended stocks.

In addition to Truist Financial, Humana also received a Hold from Deutsche Bank ‘s George Hill in a report issued on February 13. However, on February 12, Jefferies maintained a Buy rating on Humana (NYSE: HUM).

See Insiders’ Hot Stocks on TipRanks >>

Based on Humana’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $32.65 billion and a net profit of $195 million. In comparison, last year the company earned a revenue of $29.4 billion and had a net profit of $480 million

Read More on HUM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).